BRCA2 and medical procedure: The tumor suppressors BRCA1 and BRCA2 play a central role in the maintenance of chromosomal stability and germline mutations in BRCA1 and BRCA2 genes have been detected in approximately 90% of hereditary breast/ovarian cancers (49).